Cardiovascular & Vascular Research, Oncology & Senolytic Research
FOX04-DRI 10mg (Proxofim)
$284.99
FREE Shipping on orders over $200Research Studies:
- Facilitates analysis of FOXO4-p53 interaction inhibition for investigating targeted senolysis
- Supports investigation into p53-mediated mitochondrial apoptosis in senescent cell assays
- Enables research on selective elimination of senescent fibroblasts and myofibroblasts
- Useful for evaluating homeostatic recovery and cellular rejuvenation in aging-related models
Description
FOXO4-DRI 10mg (Proxofim) is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
Key Product Details
- Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
- Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
- Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
- Produced with lot-level traceability to support research documentation and laboratory recordkeeping.
Research Documentation Context
- Supports compound characterization in controlled laboratory settings.
- Provides batch-specific identity and purity documentation for research review.
- Allows lot-level traceability across laboratory documentation workflows.
- Supports comparison of product labeling, analytical documentation, and storage information during research planning.
- Supports analytical review of peptide research materials within a strictly laboratory-focused context.
Specifications and Documentation
- Certificate of Analysis: Available with batch-specific documentation where applicable.
- Material Safety Data Sheet: Coming Soon.
- Handling and Storage Instructions: Coming Soon.
- Product Form: Lyophilized powder.
- Purity Specification: ≥99% purity.
- Intended Use: Laboratory research use only.
FOXO4-DRI 10mg (Proxofim) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 2460055-10-9 |
|---|---|
| Purity | ≥99% |
| Sequence | D-(Leu-Thr-Leu-Arg-Lys-Glu-Pro-Ala-Ser-Glu-Ile-Ala-Gln-Ser-Ile-Leu-Glu-Ala-Tyr-Ser-Gln-Asn-Gly-Trp-Ala-Asn-Arg-Arg-Ser-Gly-Gly-Lys-Arg-Pro-Pro-Pro-Arg-Arg-Arg-Gln-Arg-Arg-Lys-Lys-Arg-Gly) |
| Molecular Formula | C₂₂₈H₃₈₈N₈₆O₆₄ |
| Molecular Weight | 358.06 g/mol |
| Applications | Senescence research, anti-aging studies, degenerative disease models |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Richard (verified owner) –
Good quality.
Mason (verified owner) –
The product is firmly packed.
Aiden (verified owner) –
Good quality.
Avery (verified owner) –
The product is firmly packed.
Angel (verified owner) –
Good quality.
Michael (verified owner) –
Good quality.
Edward (verified owner) –
The product is firmly packed.
Tyler (verified owner) –
The product is firmly packed.
Michael (verified owner) –
Very well worth the money.